Author Question: The nurse is preparing to administer a topical application of 1 ml of nystatin (Mycostatin) to an ... (Read 81 times)

stevenposner · **on:** Jun 28, 2018

The nurse is preparing to administer a topical application of 1 ml of nystatin (Mycostatin) to an infant with oral thrush. Which actions should the nurse plan to implement? (Select all that apply.)

a. Administer after a feeding.
b. Use a sponge applicator to swab the oral mucosa and tongue.
c. Administer after warming the medication under running warm water.
d. If white patches are no longer present, hold the medication.
e. Deposit the remainder of the dose in the mouth with a syringe so the infant swallows a small amount.

Question 2

A woman who is 6 weeks pregnant tells the nurse that she is worried that, even though she is taking folic acid supplements, the baby might have spina bifida because of a family history. The nurse's response should be based on what?

a. Prenatal detection is not possible yet.
b. There is no genetic basis for the defect.
c. Chromosome studies done on amniotic fluid can diagnose the defect prenatally.
d. Open neural tube defects (NTDs) result in elevated concentrations of -fetoprotein in amniotic fluid.

Jane · **Reply #1 on:** Jun 28, 2018

Answer to Question 1

ANS: A, B, E
To administer a topical application of nystatin for oral thrush, the medication should be distributed over the surface of the oral mucosa and tongue with an applicator or syringe. The remainder of the dose is deposited in the mouth to be swallowed by the infant to treat any gastrointestinal lesions. The nystatin should be administered after feedings. The medication should not be warmed before administration, and the medication should continue to be administered until discontinued by the health care provider.

Answer to Question 2

ANS: D
Ultrasound scanning and measurement of -fetoprotein may indicate the presence of anencephaly or myelomeningocele. The optimum time for performing this analyzing is between 16 and 18 weeks. Prenatal diagnosis is possible through amniocentesis. A multifactorial origin is suspected, including drugs, radiation, maternal malnutrition, chemicals, and possibly a genetic mutation. Chromosome abnormalities are not present in NTDs.